糖尿病下肢动脉病变的早期筛查与规范化管理  

Early screening and standardized management of artery disease in diabetic lower extremity

作　　者：吴静[1] 冉兴无[1] Wu Jing;Ran Xingwu(Innovation Center for Wound Repair,Diabetic Foot Care Center,Department of Endocrinology and Metabolism,West China Hospital of Sichuan University,Chengdu 610041,China)

机构地区：[1]四川大学华西医院内分泌代谢科,糖尿病足诊治中心,创面修复创新中心,成都610041

出　　处：《国际内分泌代谢杂志》2021年第6期587-590,共4页International Journal of Endocrinology and Metabolism

基　　金：四川省科学技术厅科研项目(2021JDKP0044);四川大学华西医院学科发展1.3.5工程项目(ZYGD18025)。

摘　　要：糖尿病下肢动脉病变是糖尿病患者常见的并发症之一,其动脉粥样硬化病理机制导致极高的心脑血管事件和下肢截肢风险,造成残疾、死亡和严重的社会经济负担。早期筛查是改善疾病预后的重要环节,结合全面的血管病变评估结果推定诊断。临床疑诊患者应立即完善全面的病情评估,并给予规范化管理。本文就糖尿病下肢动脉病变诊疗策略的临床研究进展进行综述,以加强疾病的综合管理水平。Diabetic lower extremity arterial disease is one of the common complications of diabetic patients.Its pathological mechanism of atherosclerosis makes a high risk of cardiovascular,cerebrovascular events and lower extremity amputation,causing disability,death and severe socioeconomic burden.Early screening is an important part of improving prognosis,and the timely diagnosis is presumed based on the comprehensive assessment of vascular disease.Clinical suspected patients should do an overall condition assessment immediately,then the standardized management should be given.The review summarizes the findings of the latest researches on diagnosis and treatment of diabetic lower extremity arterial disease to strengthen the level of comprehensive disease management.

关 键 词：糖尿病下肢动脉病变 动脉粥样硬化 筛查 管理 

分 类 号：R587.2[医药卫生—内分泌] R543.5[医药卫生—内科学]